u/reta_and_regret

Lost money to a shop that had nothing verifiable on file anywhere. Posting so that somebody searching that name finds this.

the timeframe matters as much as the number

The pattern in the money-loss posts, since there is one.

Almost none of them involve a documented supplier with an independent testing record. They involve an unfamiliar shop, a price that seemed good, a decision made in a hurry, and no small first order.

The procedural fix is the one this site keeps repeating: buy small from anybody new, ask for a batch-specific document before paying, test what arrives, and only then commit. It is boring, it costs a small order, and it would have prevented most of what is written on this board. Where a name has nothing verifiable on file, that is a statement about the evidence available rather than about anyone’s conduct — and keeping that distinction is why these reports stay useful.

Trial names corrected in the title. The phase 3 programme and the phase 2 readout are not the same thing.

Trial names corrected in the title. The phase 3 programme and the phase 2 readout are not the same thing.

Agreed — text only was the best rule this board ever adopted. The posts are about what actually changed rather than about lighting.

Trial names corrected in the title. The phase 3 programme and the phase 2 readout are not the same thing.

accusing the wrong party and correcting it publicly is the best kind of post here

the glucagon component is why the metabolic story reads differently

Standing reminder in every thread here: unapproved compound, research material is not for human use, nothing on this board is medical advice.

Yes. Holding the dose is a real option and it does not mean you have failed at anything.

Most of the common complaints trace back to slowed gastric emptying — early fullness, reflux, nausea after a large or fatty meal. That is also why meal size and speed change the experience more than anything else.

Not convinced comparison helps here. The people posting the fastest results are the tail of a distribution, not the middle.

Most of what gets posted here is procedural rather than dramatic: a step skipped, a document not requested, a temperature not considered, a pace chosen out of impatience.

a plateau is not a failure and it is not a personality

Is the goal you set at the start still the goal?

Standing reminder in every thread here: unapproved compound, research material is not for human use, nothing on this board is medical advice.

Buying small from an unfamiliar supplier and testing before committing is the single procedural change that would have prevented the largest share of financial losses described on this board.

Careful with the supplement recommendation. There is no evidence for it here and the mechanism you are proposing does not hold.

triple agonist — GLP-1, GIP and glucagon, and the glucagon arm is the new part

Are you eating in the couple of hours before you sleep?

the timeframe matters as much as the number

Trial names corrected in the title. The phase 3 programme and the phase 2 readout are not the same thing.

Same. Comparison ruined about three months for me until I stopped reading the fastest posts.

Removed a judgemental comment. Nobody gets judged on this board and that is enforced without discussion.

Has anyone posted an independent test on this compound recently?

Correction: that is a known effect of reduced intake rather than a direct drug effect. The distinction matters because the fix is different.

Held the dose for an extra six weeks instead of stepping. The reflux settled and I lost the same amount anyway.

Left up. It reads the phase 2 paper carefully and it is honest about the intervals.

Removed a judgemental comment. Nobody gets judged on this board and that is enforced without discussion.

Kept a one-line-a-day log for two months. The pattern was obvious on paper and invisible in my head.

Agreed — somebody is at exactly the point you were at, reading this, and it will land differently for them than any success story.

Trial names corrected in the title. The phase 3 programme and the phase 2 readout are not the same thing.

Left up. It reads the phase 2 paper carefully and it is honest about the intervals.

Right, and it bears repeating that nothing here is approved anywhere and research material is not for human use.

Weighing under consistent conditions — same time, same state, same scale — removes most of the apparent variability people find distressing.

dose escalation in the trials was slow for a reason

Removed the escalation schedule. There is no published protocol for members to follow and inventing one here is exactly what this board does not do.

This.

Agreed — and being harder on yourself than you would be on somebody else posting the same thing is the pattern here.

Trial names corrected in the title. The phase 3 programme and the phase 2 readout are not the same thing.